Stock 6815 DIAMOND BIOTECHNOLOGY CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Diamond Biotechnology Co., Ltd

Equities

6815

TW0006815004

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
102 TWD +5.48% Intraday chart for Diamond Biotechnology Co., Ltd +3.45% +16.04%
30/04 Diamond Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Diamond Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 975.4 864.9 2,416
Enterprise Value (EV) 1 1,094 963.6 2,674
P/E ratio 23.3 x 25.9 x 51.7 x
Yield 0.39% 0.35% 0.2%
Capitalization / Revenue 2.47 x 1.99 x 3.92 x
EV / Revenue 2.77 x 2.22 x 4.34 x
EV / EBITDA 13.7 x 13 x 29.2 x
EV / FCF -34.3 x 13.3 x -15.4 x
FCF Yield -2.91% 7.51% -6.5%
Price to Book 3.57 x 2.86 x 6.97 x
Nbr of stocks (in thousands) 27,485 27,485 27,485
Reference price 2 35.49 31.47 87.90
Announcement Date 26/04/22 25/05/23 30/04/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 227.6 268.4 306.4 395.2 434.8 616.1
EBITDA 1 71.26 79.07 43.16 79.64 73.94 91.48
EBIT 1 51.58 56.3 14.99 47.88 46.22 63.91
Operating Margin 22.66% 20.98% 4.89% 12.11% 10.63% 10.37%
Earnings before Tax (EBT) 1 52.39 56.55 13.5 52.05 41.82 58.33
Net income 1 41.03 44.18 11.05 41.92 33.39 46.74
Net margin 18.03% 16.46% 3.61% 10.61% 7.68% 7.59%
EPS 2 2.252 2.043 0.4020 1.525 1.215 1.700
Free Cash Flow 1 9.203 -10.88 7.724 -31.85 72.41 -173.8
FCF margin 4.04% -4.05% 2.52% -8.06% 16.65% -28.22%
FCF Conversion (EBITDA) 12.91% - 17.9% - 97.93% -
FCF Conversion (Net income) 22.43% - 69.91% - 216.86% -
Dividend per Share 2 1.864 1.119 0.0362 0.1387 0.1100 0.1801
Announcement Date 21/10/20 21/10/20 26/04/21 26/04/22 25/05/23 30/04/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 86.5 72.7 118 98.8 258
Net Cash position 1 16.9 - - - - -
Leverage (Debt/EBITDA) - 1.094 x 1.683 x 1.487 x 1.336 x 2.816 x
Free Cash Flow 1 9.2 -10.9 7.72 -31.9 72.4 -174
ROE (net income / shareholders' equity) 23% 19.9% 4.58% 16.6% 11.6% 14.4%
ROA (Net income/ Total Assets) 11.8% 9.35% 2.06% 6.11% 4.93% 5.59%
Assets 1 348.9 472.8 535.5 685.5 677 836.3
Book Value Per Share 2 9.890 9.570 8.450 9.940 11.00 12.60
Cash Flow per Share 2 2.160 2.160 2.270 1.860 3.580 2.860
Capex 1 16.6 16.6 56.4 24.9 73 197
Capex / Sales 7.28% 6.17% 18.4% 6.3% 16.78% 31.91%
Announcement Date 21/10/20 21/10/20 26/04/21 26/04/22 25/05/23 30/04/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
DIAMOND BIOTECHNOLOGY CO., LTD Stock Diamond Biotechnology Co., Ltd
+16.04% 8.63Cr
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 18TCr
MEDTRONIC PLC Stock Medtronic plc
-4.45% 10TCr
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 6.75TCr
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 4.51TCr
CENCORA, INC. Stock Cencora, Inc.
+9.70% 4.44TCr
HOYA CORPORATION Stock Hoya Corporation
+6.41% 4.07TCr
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 2.98TCr
TERUMO CORPORATION Stock Terumo Corporation
+12.14% 2.45TCr
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 2.4TCr
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. 6815 Stock
  4. Financials Diamond Biotechnology Co., Ltd